# The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach

> **NCT01933724** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University of South Florida** · enrollment: 12 (actual)

## Conditions studied

- Granulomatosis With Polyangiitis
- Wegener Granulomatosis
- Vasculitis

## Interventions

- **DRUG:** 5 mg prednisone
- **DRUG:** 0 mg prednisone

## Key facts

- **NCT ID:** NCT01933724
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-02-17
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933724, "The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01933724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*